Literature DB >> 10518561

Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase.

K Ohya1, S Kajigaya, A Kitanaka, K Yoshida, A Miyazato, Y Yamashita, T Yamanaka, U Ikeda, K Shimada, K Ozawa, H Mano.   

Abstract

Tec, Btk, Itk, Bmx, and Txk constitute the Tec family of protein tyrosine kinases (PTKs), a family with the distinct feature of containing a pleckstrin homology (PH) domain. Tec acts in signaling pathways triggered by the B cell antigen receptor (BCR), cytokine receptors, integrins, and receptor-type PTKs. Although upstream regulators of Tec family kinases are relatively well characterized, little is known of the downstream effectors of these enzymes. The yeast two-hybrid system has identified several proteins that interact with the kinase domain of Tec, one of which is now revealed to be a previously unknown docking protein termed BRDG1 (BCR downstream signaling 1). BRDG1 contains a proline-rich motif, a PH domain, and multiple tyrosine residues that are potential target sites for Src homology 2 domains. In 293 cells expressing recombinant BRDG1 and various PTKs, Tec and Pyk2, but not Btk, Bmx, Lyn, Syk, or c-Abl, induced marked phosphorylation of BRDG1 on tyrosine residues. BRDG1 was also phosphorylated by Tec directly in vitro. Efficient phosphorylation of BRDG1 by Tec required the PH and SH2 domains as well as the kinase domain of the latter. Furthermore, BRDG1 was shown to participate in a positive feedback loop by increasing the activity of Tec. BRDG1 transcripts are abundant in the human B cell line Ramos, and the endogenous protein underwent tyrosine phosphorylation in response to BCR stimulation. BRDG1 thus appears to function as a docking protein acting downstream of Tec in BCR signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518561      PMCID: PMC18397          DOI: 10.1073/pnas.96.21.11976

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Authors:  G Waksman; S E Shoelson; N Pant; D Cowburn; J Kuriyan
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

2.  Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.

Authors:  H Gu; J C Pratt; S J Burakoff; B G Neel
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

Review 3.  The PH domain: a common piece in the structural patchwork of signalling proteins.

Authors:  A Musacchio; T Gibson; P Rice; J Thompson; M Saraste
Journal:  Trends Biochem Sci       Date:  1993-09       Impact factor: 13.807

4.  Tec homology (TH) adjacent to the PH domain.

Authors:  M Vihinen; L Nilsson; C I Smith
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

5.  itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.

Authors:  J D Siliciano; T A Morrow; S V Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells.

Authors:  N Yamada; Y Kawakami; H Kimura; H Fukamachi; G Baier; A Altman; T Kato; Y Inagaki; T Kawakami
Journal:  Biochem Biophys Res Commun       Date:  1993-04-15       Impact factor: 3.575

7.  Molecular cloning and analysis of the human Tec protein-tyrosine kinase.

Authors:  K Sato; H Mano; T Ariyama; J Inazawa; Y Yazaki; H Hirai
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

9.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.

Authors:  A August; S Gibson; Y Kawakami; T Kawakami; G B Mills; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more
  13 in total

1.  Loops govern SH2 domain specificity by controlling access to binding pockets.

Authors:  Tomonori Kaneko; Haiming Huang; Bing Zhao; Lei Li; Huadong Liu; Courtney K Voss; Chenggang Wu; Martin R Schiller; Shawn Shun-Cheng Li
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

2.  Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.

Authors:  Michael Hecker; Christiane Hartmann; Ole Kandulski; Brigitte Katrin Paap; Dirk Koczan; Hans-Juergen Thiesen; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2013-05-01       Impact factor: 5.590

3.  Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2.

Authors:  Giuseppe La Venuta; Sabine Wegehingel; Peter Sehr; Hans-Michael Müller; Eleni Dimou; Julia P Steringer; Mareike Grotwinkel; Nikolai Hentze; Matthias P Mayer; David W Will; Ulrike Uhrig; Joe D Lewis; Walter Nickel
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

4.  Extensive gene-specific translational reprogramming in a model of B cell differentiation and Abl-dependent transformation.

Authors:  Jamie G Bates; Julia Salzman; Damon May; Patty B Garcia; Gregory J Hogan; Martin McIntosh; Mark S Schlissel; Pat O Brown
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

5.  Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.

Authors:  Niklas Feldhahn; Florian Klein; Jana L Mooster; Paul Hadweh; Mieke Sprangers; Maria Wartenberg; Mohamed M Bekhite; Wolf-Karsten Hofmann; Sebastian Herzog; Hassan Jumaa; Janet D Rowley; Markus Müschen
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

6.  Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans.

Authors:  Natalia Loaiza; Merel L Hartgers; Aldo Grefhorst; Jan Albert Kuivenhoven; Laurens F Reeskamp; Jan-Willem Balder; Antoine Rimbert; Venetia Bazioti; Justina C Wolters; Maaike Winkelmeijer; Hans P G Jansen; Geesje M Dallinga-Thie; Andrea Volta; Nicolette Huijkman; Marieke Smit; Niels Kloosterhuis; Mirjam Koster; Arthur F Svendsen; Bart van de Sluis; G Kees Hovingh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-30       Impact factor: 8.311

7.  Prediction of phosphotyrosine signaling networks using a scoring matrix-assisted ligand identification approach.

Authors:  Lei Li; Chenggang Wu; Haiming Huang; Kaizhong Zhang; Jacob Gan; Shawn S-C Li
Journal:  Nucleic Acids Res       Date:  2008-04-19       Impact factor: 16.971

8.  High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Elisabeth M P Steeghs; Marjolein Bakker; Alex Q Hoogkamer; Judith M Boer; Quirine J Hartman; Femke Stalpers; Gabriele Escherich; Valerie de Haas; Hester A de Groot-Kruseman; Rob Pieters; Monique L den Boer
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 9.  Genes Potentially Associated with Familial Hypercholesterolemia.

Authors:  Svetlana Mikhailova; Dinara Ivanoshchuk; Olga Timoshchenko; Elena Shakhtshneider
Journal:  Biomolecules       Date:  2019-11-29

10.  Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.

Authors:  Jun-Ichi Kashiwakura; Kodai Saitoh; Takeru Ihara; Yuto Sasaki; Kota Kagohashi; Shiyo Enohara; Yuka Morioka; Hiroshi Watarai; Ryuta Muromoto; Yuichi Kitai; Kazuya Iwabuchi; Kenji Oritani; Tadashi Matsuda
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.